医学
背景(考古学)
皮疹
移植物抗宿主病
免疫学
骨髓
疾病
造血干细胞移植
并发症
病理
内科学
生物
古生物学
作者
Robert Zeiser,Takanori Teshima
出处
期刊:Blood
[American Society of Hematology]
日期:2021-09-06
卷期号:138 (22): 2165-2172
被引量:41
标识
DOI:10.1182/blood.2021012431
摘要
Acute graft-versus-host disease (GVHD) is a major life-threatening complication after allogeneic hematopoietic cell transplantation (allo-HCT). The classical target organs of acute GVHD include the intestines, liver, and skin. The damage of these organs is relatively easy to detect for the clinician as diarrhea, increased bilirubin, and rash. However, there is increasing evidence that other organs, where the acute damage is less apparent or more difficult to distinguish from drug toxicity, such as the central nervous system, lungs, ovaries and testis, thymus, bone marrow, and kidney, can be target organs of acute GVHD. Here, we review current evidence for nonclassical manifestations of acute GVHD in rodent models and in patients and discuss them in the context of novel emerging therapies for GVHD. A better understanding of the involvement of nonclassical GVHD target organs may help to improve patient outcomes after allo-HCT.
科研通智能强力驱动
Strongly Powered by AbleSci AI